Skip to main content
SpringerLink
Log in

Acute Cerebral Infarction

Optimal Management in Older Patients

  • Review Article
  • Drug Therapy
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Summary

The optimal management of acute cerebral infarction requires consideration of the diagnosis, aetiology, identification of problems, general and specific aspects of care, and prevention of further vascular events. Stroke is a clinical diagnosis but cranial computed tomography (CT) scanning is invaluable to exclude the possibility of cerebral haemorrhage or where the diagnosis is uncertain. Good general care under a specialist multidisciplinary team can reduce mortality and the need for institutional care.

Despite promising results from experimental studies, no routine drug therapies have yet shown clinical benefit in acute stroke. Several large trials are currently evaluating anticoagulant, antiplatelet, thrombolytic and neuroprotective agents. Many other proposed therapies have been subject to limited evaluation.

Aspirin has a proven role in the prevention of further vascular events after a stroke or transient ischaemic attack. Warfarin, and to a lesser extent aspirin, can prevent recurrent events in patients with nonrheumatic atrial fibrillation. Concerns remain about the safety of warfarin in routine geriatric medical practice. The risk of recurrent stroke in patients with a symptomatic severe carotid artery stenosis is greatly reduced by endarterectomy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Article 10 October 2019

Bruce C. V. Campbell, Deidre A. De Silva, … Geoffrey A. Donnan

References

  1. Warlow C. Disorders of the cerebral circulation. In: Walton J (editor). Brain’s diseases of the nervous system. 10th ed. Oxford: Oxford University Press, 1993

    Google Scholar 

  2. Bonita R. Epidemiology of stroke. Lancet 1992; 339: 342–4

    Article  PubMed  CAS  Google Scholar 

  3. Sandercock PAG, Allen CMC, Corston RN, et al. Clinical diagnosis of intracranial haemorrhage using the Guys Hospital score. BMJ 1985; 291: 1675–7

    Article  PubMed  CAS  Google Scholar 

  4. Weir CJ, Murray GD, Adams FG, et al. Poor accuracy of stroke scoring systems for differential clinical diagnosis of intracranial haemorrhage and infarction. Lancet 1994; 344: 999–1002

    Article  PubMed  CAS  Google Scholar 

  5. van Gijn J. Subarachnoid haemorrhage. Lancet 1992; 339: 653–5

    Article  PubMed  Google Scholar 

  6. Wade D. Measurement in neurological rehabilitation. Oxford: Oxford University Press, 1992

    Google Scholar 

  7. Kidd D, Lawson J, Nesbitt R, et al. Aspiration in acute stroke: a clinical study with videofluoroscopy. Q J Med 1993; 86: 825–9

    PubMed  CAS  Google Scholar 

  8. Barer DH. The natural history and functional consequences of dysphagia after hemispheric stroke. J Neurol Neurosurg Psychiatry 1989; 52: 236–41

    Article  PubMed  CAS  Google Scholar 

  9. Langhorne P, Williams BO, Gilchrist W, et al. Do stroke units save lives? Lancet 1993; 342: 395–8

    Article  PubMed  CAS  Google Scholar 

  10. Langhorne P, Dennis MS, Williams BO. Stroke units: their role in acute stroke management. Vasc Med Rev 1995; 6: 23–34

    Google Scholar 

  11. Dennis M, Langhorne P. So stroke units save lives: where do we go from here? BMJ 1994; 309: 1273–7

    Article  PubMed  CAS  Google Scholar 

  12. Sandercock PAG, Willems H. Medical treatment of acute ischaemic stroke. Lancet 1992; 339: 537–9

    Article  PubMed  CAS  Google Scholar 

  13. Pusinelli W. Pathophysiology of acute ischaemic stroke. Lancet 1992; 339: 533–6

    Article  Google Scholar 

  14. Wardlaw JM, Warlow CP. Thrombolysis in acute ischaemic stroke: does it work? Stroke 1992; 23: 1826–39

    Article  PubMed  CAS  Google Scholar 

  15. Antiplatelet Trialists’ Collaboration. Collaborative overview of randomised trials of antiplatelet therapy — I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994; 308: 81–106

    Article  Google Scholar 

  16. Sandercock PAG, van den Belt AGM, Lindley RI, et al. Antithrombotic therapy in acute ischaemic stroke: an overview of the randomised trials. J Neurol Neurosurg Psychiatry 1993; 56: 17–25

    Article  PubMed  CAS  Google Scholar 

  17. Simoons ML, Maggioni AP, Knatterud G, et al. Individual risk assessment for intracranial haemorrhage during thrombolytic therapy. Lancet 1993; 342: 1523–8

    Article  PubMed  CAS  Google Scholar 

  18. Hommel M, Boissel JP, Cornu C, et al. Termination of trial of streptokinase in severe ischaemic stroke. Lancet 1995; 345: 57

    Article  PubMed  CAS  Google Scholar 

  19. Donnan GA, Davis SM, Chambers BR, et al. Trials of streptokinase in severe acute ischaemic stroke. Lancet 1995; 345: 578–9

    Article  PubMed  CAS  Google Scholar 

  20. Asplund K. Haemodilution in acute stroke. Cerebrovasc Dis 1991; 1 Suppl. 1: 129–38

    Article  Google Scholar 

  21. Counsell C, Sandercock P. The management of patients with acute ischaemic stroke. Curr Med Lit: Geriatr 1994; 7(4): 99–104

    Google Scholar 

  22. Pickhard JD, Murray GD, Illingworth R, et al. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ 1989; 298: 636–42

    Article  Google Scholar 

  23. Mohr JP, Orgogozo JM, Hennerici M, et al. Meta-analysis of nimodipine trials in acute ischaemic stroke. Cerebrovasc Dis 1994; 4: 197–203

    Article  Google Scholar 

  24. Bridgers SL, Koch G, Munera C, et al. Intravenous nimodipine in acute stroke: interim analysis of randomized trials. Stroke 1991; 22: 153

    Google Scholar 

  25. Wahlgren NG, MacMahon DG, de Keyser J, et al. Intravenous Nimodipine West European Stroke Trial (INWEST) of nimodipine in the treatment of acute ischaemic stroke. Cerebrovasc Dis 1994; 4: 194–6

    Article  Google Scholar 

  26. Quizilbash N, Murphy M. Meta-analysis of trials of corticosteroids in acute stroke. Age Ageing 1993; 22 Suppl. 2: 4

    Google Scholar 

  27. Rogvi-Hansen B, Boysen G. Intravenous glycerol treatment of acute stroke — a statistical overview. Cerebrovasc Dis 1992; 2: 11–3

    Article  Google Scholar 

  28. Burns J, Dennis MS, Bamford J, et al. Long-term risk of recurrent stroke after a first ever stroke: the Oxfordshire Community Stroke Project. Stroke 1994; 25: 333–7

    Article  Google Scholar 

  29. Warlow CP. Venous thromboembolism after stroke. Am Heart J 1978; 96: 283–9

    Article  PubMed  CAS  Google Scholar 

  30. Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke, and coronary heart disease: part 2. Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990; 335: 827–38

    Article  PubMed  CAS  Google Scholar 

  31. Carter AB. Hypotensive therapy in stroke survivors. Lancet 1970; 1: 485–9

    Article  PubMed  CAS  Google Scholar 

  32. Hypertension-Stroke Co-operative Study Group. Effect of anti-hypertensive treatment on stroke recurrence. JAMA 1974; 229: 409–18

    Article  Google Scholar 

  33. Lisk DR, Grotta JC, Lamki LM, et al. Should hypertension be treated after acute stroke? A randomised controlled trial using single photon emission computed tomography. Arch Neurol 1993; 50: 855–62

    Article  PubMed  CAS  Google Scholar 

  34. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383–9

    Google Scholar 

  35. Petersen P, Boysen G, Godtfredsen J, et al. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: the Copenhagen AFASAK study. Lancet 1989; 1: 175–8

    Article  PubMed  CAS  Google Scholar 

  36. Stroke Prevention in Atrial Fibrillation Investigators. Stroke prevention in atrial fibrillation study: final results. Circulation 1991; 84: 527

    Article  Google Scholar 

  37. Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 1990; 323: 1505

    Article  Google Scholar 

  38. Connolly SJ, Laupacis A, Gent M, et al. Canadian atrial fibrillation anticoagulation (CAFA) study. J Am Coll Cardiol 1991; 18: 349

    Article  PubMed  CAS  Google Scholar 

  39. Ezakowitz MD, Bridgers SL, James KE, et al. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. N Engl J Med 1992; 327: 1406–12

    Article  Google Scholar 

  40. European Atrial Fibrillation Trial Study Group. Secondary prevention in nonrheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 1993; 342: 1255–62

    Google Scholar 

  41. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994; 154: 1449–57

    Article  Google Scholar 

  42. Major ongoing stroke trials. Stroke 1994; 25 (2): 541-5

  43. Wells PS, Lensing AWA, Hirsh J. Graduated compression stockings in the prevention of postoperative venous thromboembolism: a meta-analysis. Ann Intern Med 1994; 154: 67–72

    Article  CAS  Google Scholar 

  44. Antiplatelet Trialists’ Collaboration. Collaborative overview of randomised trials of antiplatelet treatment: part 3. Reduction in pulmonary embolism and venous thrombosis by antiplatelet prophylaxis among surgical and medical patients. BMJ 1994; 304: 235–46

    Google Scholar 

  45. European Carotid Surgery Trial Collaborative Group. Medical Research Council Carotid Surgery Trial: interim results for patients with severe (70–99%) or with mild (0–30%) carotid stenosis. Lancet 1989; 1: 175–80

    Google Scholar 

  46. NASCET Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high grade stenosis. N Engl J Med 1991; 325: 445–53

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Academic Section of Geriatric Medicine, Royal Infirmary, Glasgow, G4 OSF, Scotland

    Peter Langhorne (Senior Lecturer) & David J. Stott

Authors
  1. Peter Langhorne
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David J. Stott
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Langhorne, P., Stott, D.J. Acute Cerebral Infarction. Drugs & Aging 6, 445–455 (1995). https://doi.org/10.2165/00002512-199506060-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002512-199506060-00004

Keywords

Search

Navigation